Takeda in talks with Nycomed, deal reportedly over $12 billion

percent and sales in Russia up 23.3 percent. Last year, Nycomed bought a majority stake in a Chinese pharmaceutical company, underscoring its focus on emerging markets and Western manufacturers' hunger to boost their presence in the country...